Non-invasive prenatal testing (NIPT) Market Trends

Your Catalyst To a Lucrative Business
Non-invasive prenatal testing (NIPT) Market Size, Share, Analysis,
Growth, Trends and Forecasts to 2025 | Hexa Research
“Global non-invasive prenatal testing (NIPT) market
is estimated to witness significant growth in the
coming years.”
4 March 2019, The global Non-Invasive Prenatal Testing (NIPT) Market is estimated to witness significant
growth in the coming years due to growing popularity of non-invasive procedures. Improvement in
reimbursement policies and introduction of advanced NIPT products are likely to support market growth. Rising
awareness regarding these tests across the globe is also poised to create lucrative opportunities in the future.
In present days, obstetricians are extensively suggesting these tests for early diagnostic screening in the first
trimester of pregnancy.
Prenatal testing helps in determining the possibility of fetal abnormality. Development of these tests in a
noninvasive form helps avoid expensive and risky invasive procedures such as chorionic villus sampling (CVS)
and amniocentesis. Improvements by payers in coverage related to average risk pregnancy tests are anticipated
to fuel the adoption of amniocentesis tests and Down's Syndrome treatment. This, in turn, is estimated to
augment adoption rate of non-invasive prenatal aids.
Growing maternal age is projected to unfold ample growth opportunities in the market. Advancing maternal
age is responsible for several health complications such as high blood pressure, reduced fertility, risk of
miscarriage, and maternal death. It also increases the risk of chromosomal abnormalities in babies. Possible
abnormalities in babies may include poor muscle tone, breathing complaints, heart related problems, and
others. Increasing consciousness regarding prevention and screening of chromosomal anomalies can boost
market growth in the coming years.
Browse Details of Report @ https://www.hexaresearch.com/research-report/non-invasive-prenatal-testingnipt-market
Follow Us:
Your Catalyst To a Lucrative Business
However, presence of strict regulatory framework regarding approval of medical devices can hinder the growth
of the market. Lengthy approval procedures delay innovation and development of devices. In addition, lack of
skilled professionals is also expected to restrain the growth of the non-invasive prenatal testing market.
Various techniques involved in NIPT tests include fetal cells in maternal blood tests, cell-free DNA in maternal
plasma tests, biochemical screening tests, and ultrasound detection. Cell-free DNA in maternal plasma tests are
anticipated to witness an upswing in their demand in the coming years. This can be attributed to growing
requirement for cf-DNA-based techniques in NIPT testing. In addition, increasing government efforts for
providing prenatal services are likely to stir up the demand for these tests.
North America is considered as one of the attractive markets in the global arena. High government spending for
research and development (R&D) activities and development of whole genome sequencing as a result of
availability of technologically advanced and presence of established healthcare research framework have been
providing an upthrust to the regional market.
On the other hand, Asia Pacific is poised to exhibit noteworthy growth in the coming years. Rising average
maternal age, improving healthcare facilities, rising disposable income, and high prevalence of chromosomal
abnormalities are some of the primary growth stimulants for the regional market. Advancing maternal age and
high-risk pregnancies in China are projected to create lucrative growth opportunities for the regional market in
near future.
Countries such as Japan and China are sights of high growth rates in the region. Additionally, improvement in
healthcare facilities along with growing exposure for clinical research in India and Australia are also projected
to support the growth of the market in APAC in the coming years.
Some of the key players operating in the global non-invasive prenatal testing market are Sequenom Inc.;
PerkinElmer, Inc.; Agilent Technologies, Inc.; Pacific Biosciences of California, Inc.; and Quest Diagnostics.
Various laboratories and companies are collaborating with test provides for providing latest products and
services to patients. This is anticipated to work in favor of the market.
In addition, public health agencies in major economies in the world are providing these tests directly, which is
expected to bode well for the market. Companies are concentrating on development and launch of advanced
tests. For instance, LifeCell, stem cell bank from India, introduced 'Pentastic', an ultrasound and biochemistry based blood test. This test has to be carried out in the first trimester of pregnancy between 11 to 13 weeks. The
screening can be performed to detect abnormalities related to genes and structural malformations in fetus. The
test is also helpful to examine serious high blood pressure in pregnancy.
Browse Related Category Market Reports@ https://www.hexaresearch.com/researchcategory/clinical-diagnostics-industry
Follow Us:
Your Catalyst To a Lucrative Business
About Us:
Hexa Research is a market research and consulting organization, offering industry reports, custom research
and consulting services to a host of key industries across the globe. We offer comprehensive business
intelligence in the form of industry reports which help our clients obtain clarity about their business
environment and enable them to undertake strategic growth initiatives.
Contact Us:
Ryan Shaw
Hexa Research
Felton Office Plaza
6265 Highway 9
Felton, California 95018
United States
Phone: +1-800-489-3075
Email: sales@hexaresearch.com
Website - https://www.hexaresearch.com
Follow Us:

The global non-invasive prenatal testing (NIPT) market is estimated to witness significant growth in the coming years due to growing popularity of non-invasive procedures.